Filter Results:
(2,462)
Show Results For
- All HBS Web
(2,462)
- People (6)
- News (577)
- Research (1,760)
- Events (11)
- Multimedia (14)
- Faculty Publications (1,391)
Show Results For
- All HBS Web
(2,462)
- People (6)
- News (577)
- Research (1,760)
- Events (11)
- Multimedia (14)
- Faculty Publications (1,391)
- June 5, 2023
- Article
How to Tap the Full Potential of Telemedicine
By: Mitchell Tang, Louise Short, Ryan June, Matthew Dowling and Ateev Mehrotra
Telemedicine visits in the United States have fallen sharply since April 2020, but the end of the pandemic should not spell the end of telemedicine. It can play a valuable role in the delivery of health care. The key to tapping its potential is to bring many elements... View Details
Tang, Mitchell, Louise Short, Ryan June, Matthew Dowling, and Ateev Mehrotra. "How to Tap the Full Potential of Telemedicine." Harvard Business Review (website) (June 5, 2023).
- May 1993
- Case
Patient Transfusion Services Lab of Central Blood Bank
By: James L. Heskett
The vice president of the Lab and Clinical Services at Central Blood Bank is faced with the challenge of convincing a hospital to use economical shared patient transfusion testing services. View Details
Keywords: Health Care and Treatment; Quality; Service Operations; Mathematical Methods; Customer Satisfaction; Health Industry
Heskett, James L. "Patient Transfusion Services Lab of Central Blood Bank." Harvard Business School Case 693-091, May 1993.
- October 2010 (Revised November 2010)
- Background Note
Plavix: Drugs in the Age of Personalized Medicine
By: Richard G. Hamermesh, Mara G. Aspinall and Rachel Gordon
PIavix, one of the world's best selling drugs in 2010, appears to have a limited future. Its patent was due to expire soon, and recently new data had been discovered that indicated that a small subset of the population would be at risk for stroke, heart attack, or even... View Details
Keywords: Health Care and Treatment; Product Positioning; Business and Government Relations; Genetics; Competitive Strategy; Pharmaceutical Industry
Hamermesh, Richard G., Mara G. Aspinall, and Rachel Gordon. "Plavix: Drugs in the Age of Personalized Medicine." Harvard Business School Background Note 811-001, October 2010. (Revised November 2010.)
- August 2014
- Case
Blue Cross Blue Shield of Florida, Inc.
By: Regina E. Herzlinger and Meng Li
Keywords: Health; Health Care Industry; Health Insurance; United States; Health Care and Treatment; Health Industry; United States; Florida
Herzlinger, Regina E., and Meng Li. "Blue Cross Blue Shield of Florida, Inc." Harvard Business School Case 315-009, August 2014.
- 31 Mar 2023
- Research & Ideas
Can a ‘Basic Bundle’ of Health Insurance Cure Coverage Gaps and Spur Innovation?
Professor of Public Policy at Harvard’s John F. Kennedy School of Government, conducted the research with Katherine Baicker of the University of... View Details
- 2020
- Working Paper
Mission-Oriented Research in a National Emergency: Lessons from the Office of Scientific Research and Development in World War II
By: Daniel P. Gross and Bhaven N. Sampat
Since the beginning of the present COVID-19 pandemic, policymakers, researchers, and journalists have made repeated comparisons to World War II. In ongoing research, we have been studying the effects of the World War II research effort, which included a major medical... View Details
- 15 Aug 2015
- News
Victoria Tsai: Skin Secrets of a Geisha
- 23 Feb 2021
- Cold Call Podcast
Examining Race and Mass Incarceration in the United States
Keywords: Re: Reshmaan N. Hussam
- 2025
- Working Paper
Expert Patients’ Use of Avoidable Health Care
By: Amitabh Chandra, Pragya Kakani and Simone Matecna
We measure whether expert patients – those trained as physicians and nurses – have fewer emergency department visits and the reasons for these differences. Relative to similar patients physicians and nurses had 19.8% and 5.1% fewer ED visits, principally due to fewer... View Details
Chandra, Amitabh, Pragya Kakani, and Simone Matecna. "Expert Patients’ Use of Avoidable Health Care." NBER Working Paper Series, No. 33573, March 2025.
- July 1991 (Revised July 1993)
- Case
Alliant Health System: A Vision of Total Quality
Alliant has been a leader in the health care industry in implementing total quality management. After five years, however, they do not have much to show for their efforts except a "foundation" of quality attitudes and processes. The case discusses their plans to "jump... View Details
Keywords: Quality; Management Practices and Processes; Information Technology; Health Care and Treatment; Health Industry
Linder, Jane C. "Alliant Health System: A Vision of Total Quality." Harvard Business School Case 192-003, July 1991. (Revised July 1993.)
- 2024
- Working Paper
Cephalosporins—Fighting Hospital Infections: Case Histories of Transformational Advances
By: Amar Bhidé, Srikant Datar and Katherine Stebbins
This case history describes the development of three generations of cephalosporins – antibiotics that have significantly reduced hospital infections. Specifically, we chronicle how: 1) Early (pre-cephalosporin) antibiotics were developed in the first half of the 20th... View Details
Keywords: Health Care and Treatment; Technological Innovation; Innovation Strategy; Technology Adoption; Collaborative Innovation and Invention; Innovation and Invention; Governing Rules, Regulations, and Reforms
Bhidé, Amar, Srikant Datar, and Katherine Stebbins. "Cephalosporins—Fighting Hospital Infections: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 20-133, July 2020. (Revised May 2024.)
- November 2009
- Case
The Explosion of Genetic Testing: Opportunities and Challenges
By: Richard G. Hamermesh, Mara G. Aspinall and Rachel Gordon
This case study invites the reader to consider genetic testing in several different lights. First, can the business of genetic testing be considered a disruptive innovation to the current drug therapy model as defined by Harvard Business School Professor Clay... View Details
- 29 Mar 2008
- Research & Ideas
Creativity, Entrepreneurship, and Organizations of the Future
Additionally, the need to balance creative thinking with accountability and responsibility was emphasized. This was a novel twist to the usually laudatory treatment that creativity gets, exposing the darker side View Details
Keywords: by Teresa M. Amabile & Mukti Khaire
- Article
The Implications of the 2010 Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act on Cancer Care Delivery
By: Heidi W. Albright, Mark Moreno, Thomas W. Feeley, Ronald Walters, Marc Samuels, Alissa Pereira and Thomas W. Burke
In March 2010, President Obama signed into law the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act. This legislation attempts to address cost control and improve the quality of healthcare in the United States. Cancer is a... View Details
Keywords: Health Care Policy; Health Care; Cancer Care In The U.S.; Cancer Care Services; Health; Law; Quality; Health Industry; North and Central America
Albright, Heidi W., Mark Moreno, Thomas W. Feeley, Ronald Walters, Marc Samuels, Alissa Pereira, and Thomas W. Burke. "The Implications of the 2010 Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act on Cancer Care Delivery." Cancer 117, no. 8 (April 15, 2011): 1564–1574.
- 16 Jul 2012
- Working Paper Summaries
Selection, Reallocation, and Spillover: Identifying the Sources of Gains from Multinational Production
Keywords: by Laura Alfaro & Maggie X. Chen
- October 2013
- Article
Barriers to Completion of Patient Reported Outcome Measures
By: Elizabeth H. Schamber, Steven K. Takemoto, Kate Eresian Chenek and Kevin J. Bozic
Patient Reported Outcomes Measures (PROMs) are commonly used in total joint arthroplasty (TJA) to assess surgical outcomes. However certain patient populations may be underrepresented due to lower survey completion rates. The purpose of this study is to evaluate... View Details
Keywords: Patient Reported Outcome Measures; PROM; Total Joint Arthroplasty; Hip; Knee; Electronic Survey; Equality and Inequality; Demographics; Surveys; Health Care and Treatment; Health Industry
Schamber, Elizabeth H., Steven K. Takemoto, Kate Eresian Chenek, and Kevin J. Bozic. "Barriers to Completion of Patient Reported Outcome Measures." Journal of Arthroplasty 28, no. 9 (October 2013).
- September–October 2023
- Article
Prospective Evaluation of the Cost of Performing Breast Imaging Examinations Using Time-Driven Activity-Based Costing Method: A Single Center Study
By: Aamir Ali, Jordana Phillips, Damir Ljuboja, Syed S. Shehab, Etta D. Pisano, Robert S. Kaplan and Ammar Sarwar
We use time-driven activity-based costing (TDABC) to measure the cost of performing breast imaging using different modalities: full-field digital mammography (FFDM), digital breast tomosynthesis (DBT), contrast-enhanced mammography (CEM), US and MRI exams, and... View Details
Keywords: Time-Driven Activity-Based Costing; Health Care; Breast Cancer; Health Care and Treatment; Cost; Cost Accounting; Health Industry
Ali, Aamir, Jordana Phillips, Damir Ljuboja, Syed S. Shehab, Etta D. Pisano, Robert S. Kaplan, and Ammar Sarwar. "Prospective Evaluation of the Cost of Performing Breast Imaging Examinations Using Time-Driven Activity-Based Costing Method: A Single Center Study." Journal of Breast Imaging 5, no. 5 (September–October 2023): 546–554.
- 08 Mar 2019
- Blog Post
Reclaiming Feminism: A Celebration of International Women’s Day
but I stand as 10,000." We stand on the shoulders of giants and are reaching back for those who come behind us. Lieutenant Commander Alison Wagner (MBA '19) To me, feminism is synonymous with advocacy—advocating for equal rights and... View Details
- January 2011 (Revised January 2012)
- Supplement
The Case of the Unidentified Healthcare Companies2010 (CW)
By: Richard M.J. Bohmer, Ethan S Bernstein, Margarita Krivitski and Srinidhi Reddy
This case presents financial statements and selected rations for 14 unidentified healthcare organizations and asks that each set of financial information be matched with one of the following healthcare companies: a biotechnology firm, a community nursing company, a... View Details
- 14 Mar 2016
- Working Paper Summaries